ArticleWorld journal of urology2025
Predicting surgical outcomes in single-port robot-assisted partial nephrectomy: external validation and comparative analysis of PADUA, RENAL, and SPARE scores.
Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Anatomy and patient comorbidity in robotic partial nephrectomy: predictors of complexity and outcomes.Journal of robotic surgery · 2026Article
- Single-port versus multi-port robot-assisted partial nephrectomy: a multivariate analysis of the surgical trifecta.Journal of robotic surgery · 2026Article
- Single-port robotic surgery for kidney and upper tract cancer: a narrative review.Translational andrology and urology · 2026Review
- Surgical Determinants of Outcomes in Partial Nephrectomy: a Contemporary Review.Current urology reports · 2026Review
- Robot-assisted laparoscopic simultaneous bilateral partial nephrectomy for bilateral renal carcinoma: a case report.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeNephrometry scores are essential tools for classifying and comparing tumor complexity and guiding surgical planning in partial nephrectomy. However, their performance in single-port robot-assisted partial nephrectomy (SP-RAPN) has not been formally assessed. We aimed to externally validate and compare the predictive performance of the Preoperative Aspects and Dimensions Used for an Anatomical (PADUA), Radius-Exophytic/Endophytic-Nearness-Anterior/Posterior-Location (RENAL), and Simplified PADUA Renal (SPARE) nephrometry scores in patients undergoing SP-RAPN.
methodsWe retrospectively reviewed 211 consecutive patients who underwent SP-RAPN for solitary ≤ cT2 renal tumors at two academic centers between 2019 and 2024. The primary endpoint was Trifecta achievement, defined as the simultaneous presence of negative surgical margins, absence of perioperative complications, and warm ischemia time ≤ 25 min. Discrimination and clinical utility of each nephrometry score were assessed using receiver operating characteristic (ROC) curve analysis and decision curve analysis (DCA). Multivariable logistic regression adjusted for relevant clinical covariates.
resultsTrifecta was achieved in 50.7% of patients. The SPARE score demonstrated the highest discriminative performance (AUC 0.681), followed by PADUA (0.661) and RENAL (0.654), though these differences were not statistically significant. DCA showed overlapping net benefit curves, with SPARE offering marginally superior. Limitations include the retrospective design and underrepresentation of highly complex tumors.
conclusionsPADUA, RENAL, and SPARE scores show comparable performance in predicting Trifecta achievement in the setting of SP-RAPN. SPARE may perform slightly better, and it represents a more practical choice for routine preoperative assessment due to its ease of use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.